Livderm

💜 June 1–7 marks HS Awareness Week—a time to raise awareness of this chronic inflammatory skin condition affecting nearly 3 million people in the U.S.

HS causes painful nodules, abscesses, and tunnels beneath the skin, yet it's often misdiagnosed. Early recognition and support can make all the difference.

Whether you're living with HS, treating patients, or want to learn more—let's unite to raise awareness and support the HS community.

🔗 Read the full article and explore resources here: https://go.livderm.org/4fpWc8K

We're excited to introduce our Medical Dermatology Chair for South Beach Symposium 2027!

Christopher Bunick, MD, PhD, is an associate professor of dermatology at Yale University School of Medicine, advising students in general medical dermatology and dermatologic surgery. In his clinical practice at Yale Dermatology Associates he provides care for patients with a wide range of dermatological conditions.

Dr. Bunick’s laboratory research aims to use X-ray crystallography, cryo-electron microscopy, and biochemistry to better understand the structure-function relationship of proteins involved in normal and diseased skin.

With his expertise bridging clinical excellence and cutting-edge research, Dr. Bunick is shaping an exceptional Medical Dermatology program for South Beach Symposium 2027.

📍 Feb. 4-6, 2027 | Miami Beach
🔗 Register now: https://go.livderm.org/4v7Grrt

New targeted topicals are transforming pediatric atopic dermatitis care.

Recent approvals of non-steroidal topicals, including PDE4 inhibitors, JAK inhibitors, and AhR agonists, for younger patients represent a major shift in care.

Enroll in our latest accredited activity with board-certified dermatologist Peter A. Lio, MD, and master these breakthrough therapies.

Learn:
✔️ AD pathophysiology & management guidelines
✔️ Clinical efficacy & safety data
✔️ Treatment selection & application pearls
✔️ Emerging therapies

🔗 Enroll now: https://go.livderm.org/3PA8f8V

This activity is supported by an educational grant from Arcutis Biotherapeutics, Inc.

With June marking Hidradenitis Suppurativa Awareness Month, we are turning our attention to one of the most difficult aspects of this chronic inflammatory skin disease, the pain.

In addition to the painful and recurrent nodules and abscesses, hidradenitis suppurativa (HS) also involves significant psychosocial burden which can greatly affect a patient's quality of life.

In this week's blog, we explore the mechanisms behind HS pain, the current treatment approaches, and how providers can better manage this challenging condition.

🔗 Read the full blog here: https://go.livderm.org/42Z7xoK

This Memorial Day, we honor those who served with courage and sacrifice.

As we reflect and spend time with loved ones, we're also celebrating a major milestone: 25 years of the South Beach Symposium (SBS)!

To celebrate Memorial Day weekend AND our 25th anniversary:
✨ Enjoy 25% off sitewide for the next 25 hours using code: CELEBRATE25

🔗 Register now: https://go.livderm.org/4nPzYin

*Code valid for SBS and MOPD 2027. Cannot be applied to previous purchases. One discount per customer, per transaction.

The role of dermatology nurses cannot be overstated.

They bridge the gap between providers and patients—ensuring clear communication, patient education, treatment adherence, and compassionate care every step of the way.

Dermatology nurses are vital to supporting both patients and clinicians, helping foster an environment where high-quality treatment and patient-centered care can thrive.

🔗 Read now: https://go.livderm.org/49aVZlY

Premier dermatology education, all year long. 📚

Whether or not you attended South Beach Symposium (SBS) or Masters of Pediatric Dermatology (MOPD), LiVDerm is here to support your professional growth all year long.

Access now:
✔️ Latest educational activities
✔️ CME opportunities
✔️ Clinical resources

Stay tuned for upcoming course launches—and mark your calendars for next year's live SBS and MOPD events.

🔗 Explore LiVDerm: https://go.livderm.org/4a2rfnj

Chronic skin diseases such as acne, psoriasis, atopic dermatitis, and alopecia areata can significantly impact quality of life, self-esteem, and emotional well-being.

Taking a more holistic approach to care–including recognizing psychological burden and supporting patients beyond the skin–remains an important part of clinical practice.

This Mental Health Awareness Month, let's continue prioritizing compassionate, patient-centered care that addresses both physical and emotional health.

The management of chronic spontaneous urticaria (CSU) is evolving fast—with new BTK inhibitors and anti-IL-4Rα biologic therapies changing the treatment landscape.

Join Dr. Christopher G. Bunick, MD, PhD in this on-demand CME activity recorded at the 2026 South Beach Symposium.

What you'll learn:
✔️ Chronic urticaria overview and differential diagnosis
✔️ Current CSU management recommendations
✔️ FDA-approved second-line therapies and emerging agents

Earn 0.50 CME credits while staying current on the latest evidence-based approaches.

🔗 Start the activity now: https://go.livderm.org/4dCYS0h

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

🔬 The treatment landscape for moderate-to-severe atopic dermatitis (AD) is evolving. While traditional biologics have paved the way, the clinical focus is now shifting toward the OX40/OX40L pathway.

💡 Join board-certified dermatologists Christopher G. Bunick, MD, PhD, and Emma Guttman-Yassky, MD, PhD, for an interactive deep dive into the next generation of T cell-mediated therapies.

📚 Enroll in our accredited activity: "Expanding the AD Toolb-OX: A New Pathway for Treating Moderate-to-Severe Disease".

What You'll Learn:
✅ Gaps in AD care
✅ AD pathogenesis
✅ OX40- and OX40L-targeted therapies
✅ The future of AD care

🎓 Earn 1.00 CME Credit

🔗 Start activity now: https://go.livderm.org/4d7Mgz5